About Diagnosia
Diagnosia is a company based in Vienna (Austria) founded in 2011 by Eric Pfarl. Diagnosia has raised $1.36 million across 2 funding rounds from investors including FFG Austrian Research Promotion Agency. Diagnosia offers products and services including Diagnosia App, Barcode Scanner, and Medical Podcasts. Diagnosia operates in a competitive market with competitors including MMIT Network, Yuimedi, Posos, Memed and Wolters Kluwer Clinical Drug Information, among others.
- Headquarter Vienna, Austria
- Founders Eric Pfarl
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Apoverlag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.36 M (USD)
in 2 rounds
-
Latest Funding Round
$1.36 M (USD), Angel Round
Oct 09, 2013
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Diagnosia
Diagnosia offers a comprehensive portfolio of products and services, including Diagnosia App, Barcode Scanner, and Medical Podcasts.
Provides drug information and interactions for quick physician access.
Scans medications for fast data retrieval.
Delivers audio on medical topics for professional development.
Funding Insights of Diagnosia
Diagnosia has successfully raised a total of $1.36M across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $1.36 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Diagnosia
Diagnosia has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FFG Austrian Research Promotion Agency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Management consulting and business management services are provided by FFG.
|
Locked | Locked | Locked |
Investor details for Diagnosia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Diagnosia
Investment portfolio details for Diagnosia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Diagnosia
Detailed financials for Diagnosia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Diagnosia Comparisons
Peer comparison for Diagnosia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Diagnosia
Diagnosia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MMIT Network, Yuimedi, Posos, Memed and Wolters Kluwer Clinical Drug Information, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers formulary data & analytics for market research, medication decision & formulary management
|
|
| Locked | Locked | Locked |
Provider of medical data analysis platform to improve the healthcare system
|
|
| Locked | Locked | Locked |
AI-based drug information and patient profiling tool for healthcare professionals
|
|
| Locked | Locked | Locked |
Application with curated drug information used by physicians
|
|
| Locked | Locked | Locked |
Offers software and services for healthcare, tax, accounting, finance, and legal professionals.
|
|
| Locked | Locked | Locked |
Online database solutions for pharmaceutical R&D are offered.
|
Detailed competitors of Diagnosia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Diagnosia
Complete news archive for Diagnosia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Diagnosia
Diagnosia was founded in 2011.
Diagnosia is headquartered in Vienna, Austria.
Diagnosia is a funded company, having raised a total of $1.36M across 2 funding rounds to date.
Diagnosia was founded in 2011 in Vienna, Austria, within the e-health sector. A drug search engine is offered to healthcare professionals, supported by mobile and web-based decision tools. Details on drug dosage, administration methods, frequency, side effects, and composition are maintained. A consumer-oriented search engine called Medikamio has been introduced for physicians and pharmacists. Implementations have occurred in more than 65 hospitals in Austria, Germany, and Switzerland.
Diagnosia's top competitors include MMIT Network, Posos and Memed.
Diagnosia offers Diagnosia App, Barcode Scanner, and Medical Podcasts.
Diagnosia has 1 investor. Key investors include FFG Austrian Research Promotion Agency.